C. Fernandez-patron et al., Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction, CIRCUL RES, 87(8), 2000, pp. 670-676
Matrix metalloproteinase (MMP)-2 has been historically associated with the
process of vascular remodeling through the cleavage of extracellular matrix
proteins. However, we recently found that MMP-2 also cleaves the endotheli
um-derived peptide big endothelin-l, ET-l[1-38] and yields the novel vasoco
nstrictor ET-l[1-32,]. We therefore investigated the effects of MMP-2 inhib
itors as potential vasodilators, MMP inhibition with orthophenanthroline (0
.3 to 30 mu mol/L) induced vasorelaxation of isolated rat mesenteric arteri
es (maximum of relaxation=74.5+/-27.6% at 30 mu mol/L). However, phosphoram
idon (0.3 to 30 mu mol/L), which inhibits some metalloenzymes, but not MMP-
2, did not dilate the arteries. Selective inhibition of endogenous MMP-2 wi
th the novel tissue-permeable cyclic peptide CTTHWGFTLC (CTT, 10 mu mol/L)
also caused vasorelaxation (by 85+/-6%), whereas STTHWGFTLS (10 mu mol/L),
an inactive CTT analogue, did not dilate the arteries. Interestingly, the v
asorelaxation that results from MMP-2 inhibition was endothelium-independen
t. Thus, we examined whether MMP-2 acted on peptides derived from the smoot
h muscle or the perivascular nerves, Recombinant human MMP-2 cleaved calcit
onin gene-related peptide (CGRP) specifically at the Gly(14)-Leu(15) peptid
e bond and reduced the vasodilatory potency of CGRP by 20-fold. Inhibition
of MMP-2 increased the amount of intact CGRP in arteries and enhanced vasor
elaxation induced by anandamide, which stimulates CGRP release. Vasorelaxat
ion in response to MMP-2 inhibition was abolished by CGRP[8-37], a selectiv
e CGRP receptor antagonist, and by capsaicin, which depletes arterial periv
ascular nerves of CGRP. We conclude that vascular MMP-2 cleaves endogenous
CGRP and promotes vasoconstriction, These data suggest a novel mechanism of
regulating the vasoactive and, possibly, the neurohormonal actions of CGRP
and establish MMP-2 as a modulator of vascular function.